I think it plants these seeds of doubt in anybody's head about what is in a vaccine. And that's a huge myth
Newspapers and networks are wary of exposing their staff members to the president and his aides, saying they do not have assurance that basic precautions will be taken to protect reporters’ health.
MoreSome 100 election observers from the OSCE Parliamentary Assembly will deploy later this month to the United States for the 3 November general elections. They will work with about 40 long-term observers and experts from the OSCE Office for Democratic Institutions and Human Rights who are already in the country and deliver a joint assessment
MoreThe Elecsys® SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of SARS-CoV-2 infection
MoreToday, the Commission announces the first provisional results of the implementation of the Coronavirus Response Investment Initiative (CRII) and Coronavirus Response Investment Initiative Plus (CRII+).
MoreThis morning, the President of the European Commission, Ursula von der Leyen, addressed the opening session of this year's edition of the European Week of Regions and Cities via videoconference.
MoreOne of the challenges of measuring the economy through the pandemic has been estimating the contribution of the public sector, when the relationship between public spending and outputs – for example classes taught or operations conducted – is very different from pre-COVID-19 times. Katherine Mills talks about how we’ve approached the issue.
MoreA challenge faced by the ONS during the pandemic is the inability to conduct face-to-face household interviews, having to rely on telephone surveys instead. So we’ve been exploring how this might have affected responses to our Labour Force Survey on which the key UK employment data are based. Jonathan Athow explains what we have
MoreThe government’s Job Support Scheme (JSS) will be expanded to protect jobs and support businesses required to close their doors as a result of coronavirus restrictions, the Chancellor announced today.
MoreSix new projects worth a total of £2 million will give a much-needed boost in support for research investigating the impact of the COVID-19 pandemic on mental health.
MoreIn a continuing effort to provide the facts about ID NOW to support public health interests, Abbott (NYSE: ABT) is sharing new interim clinical data results on its ID NOW COVID-19 rapid test. The results confirm the data submitted to the U.S. Food and Drug Administration (FDA) in March for Emergency Use Authorization (EUA) and
More